Skip to main content

Table 2 The immunization and challenge methods in the treatment groups in the survival rate experiment

From: Recombinant tandem epitope vaccination provides cross protection against Actinobacillus pleuropneumoniae challenge in mice

Group Group name Number of animals immunization Dose of immunization Challenge
1 PBSC1 10 PBS 0.2 mL/per mouse APP1
2 PBSC5 10 PBS 0.2 mL/per mouse APP5b
3 RTAC1 10 RTA 100 μg/0.2 mL/per mouse APP1
4 IB1-C1 10 inactivated APP1 108 CFU of APP1/0.2 mL/per mouse APP1
5 IB1-C5 10 inactivated APP1 108 CFU of APP1/0.2 mL/per mouse APP5b
6 IB5-C1 10 inactivated APP5b 108 CFU of APP5b/0.2 mL/per mouse APP1
7 IB5-C5 10 inactivated APP5b 108 CFU of APP5b/0.2 mL/per mouse APP5b
8 RTAIB1 + C1 6 RTA +inactivated APP1 100 μg of RTA + 108 CFU of APP1/0.2 mL/per mouse APP1
9 RTAIB1 + C5 6 RTA +inactivated APP1 100 μg of RTA + 108 CFU of APP1/0.2 mL/per mouse APP5b
10 RTAIB5 + C1 6 RTA +inactivated APP5b 100 μg of RTA + 108 CFU of APP5b/0.2 mL/per mouse APP1
11 RTAIB5 + C5 6 RTA +inactivated APP5b 100 μg of RTA + 108 CFU of APP5b/0.2 mL/per mouse APP5b
  1. Scheme parameters: Observation of the survival rate